Prescription psychostimulants, atomoxetine and the risk of psychosis in adults with history of psychosis: a population-based cohort study. [PDF]
Bach P +5 more
europepmc +1 more source
Management of Central Disorders of Hypersomnolence in Pregnancy and Lactation. [PDF]
Abideen ZU +5 more
europepmc +1 more source
Comparative efficacy of new wake-promoting agents for narcolepsy-a network meta-analysis. [PDF]
Yan Z +5 more
europepmc +1 more source
Advances in Non-CPAP Management of Obstructive Sleep Apnea: Spotlight on Pharmacological Therapies. [PDF]
Siciliano M +5 more
europepmc +1 more source
Efficacy of Fatigue Countermeasures on Cognitive Performance and Operational Safety in Military Pilots: A Systematic Review. [PDF]
Attiah Alzahrani A +3 more
europepmc +1 more source
Management of Narcolepsy: Defining the Role of Modafinil
Narcolepsy is a chronic sleep disorder characterised by excessive daytime sleepiness, with or without cataplexy, sleep paralysis and hypnagogic hallucinations, with an estimated prevalence of 0.02 to 0.05% worldwide. The goal of managing narcolepsy is to
Alison M. Comer, Caroline M. Spencer
core
Reduced risk of cause-specific hospitalisations and all-cause hospitalisation/mortality during treatment with attention-deficit/hyperactivity disorder medications in the course of bipolar disorder: a Swedish registry-based within-subject cohort study. [PDF]
Ermis C +8 more
europepmc +1 more source
Sleep disorders in Parkinson's disease: evaluating pharmacological treatments through systematic review and meta-analysis. [PDF]
Li J +5 more
europepmc +1 more source
Clinical pearls for the treatment of narcolepsy. [PDF]
Bulloch MN, Geyer JD.
europepmc +1 more source
Off-label and investigational drugs in the treatment of gambling disorder: a critical review. [PDF]
Bissig L, Mutschler J.
europepmc +1 more source

